Literature DB >> 29353063

Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques.

Hans-Gert Bernstein1, Henrik Dobrowolny2, Gerburg Keilhoff3, Johann Steiner2.   

Abstract

There is evidence from in vitro experiments that dipeptidyl peptidase IV (DPP IV) might play role(s) in amyloid formation. However, nothing is known about the localization of the enzyme in brains of individuals with Alzheimer's disease. We herein show that in comparison to non-demented controls DPP IV is upregulated in AD brain neurons and occurs in multiple amyloid plaques.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Amyloid; DPP IV; Immunohistochemistry; Neurons

Mesh:

Substances:

Year:  2018        PMID: 29353063     DOI: 10.1016/j.neuint.2018.01.005

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  11 in total

1.  Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia.

Authors:  Luodan Yang; Yan Dong; Chongyun Wu; Yong Li; Yichen Guo; Baocheng Yang; Xuemei Zong; Michael R Hamblin; Timon C-Y Liu; Quanguang Zhang
Journal:  J Biophotonics       Date:  2019-02-14       Impact factor: 3.207

Review 2.  SARS-COV-2 - the pandemic of the XXI century, clinical manifestations - neurological implications.

Authors:  Vicentiu Saceleanu; Mihai-Stelian Moreanu; Razvan-Adrian Covache-Busuioc; Aurel George Mohan; Alexandru-Vlad Ciurea
Journal:  J Med Life       Date:  2022-03

Review 3.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

Review 4.  The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.

Authors:  H C Yashavantha Rao; Chelliah Jayabaskaran
Journal:  J Med Virol       Date:  2020-04-29       Impact factor: 2.327

Review 5.  Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV2.

Authors:  Debanjana Chakravarty; Jayasri Das Sarma
Journal:  J Neurovirol       Date:  2021-02-05       Impact factor: 2.643

6.  Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients.

Authors:  Julie Helms; Stéphane Kremer; Hamid Merdji; Malika Schenck; François Severac; Raphaël Clere-Jehl; Antoine Studer; Mirjana Radosavljevic; Christine Kummerlen; Alexandra Monnier; Clotilde Boulay; Samira Fafi-Kremer; Vincent Castelain; Mickaël Ohana; Mathieu Anheim; Francis Schneider; Ferhat Meziani
Journal:  Crit Care       Date:  2020-08-08       Impact factor: 9.097

Review 7.  SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms.

Authors:  Manuela Pennisi; Giuseppe Lanza; Luca Falzone; Francesco Fisicaro; Raffaele Ferri; Rita Bella
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

Review 8.  A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system.

Authors:  Anastasia Williams; Heather Branscome; Pooja Khatkar; Gifty A Mensah; Sarah Al Sharif; Daniel O Pinto; Catherine DeMarino; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2021-09-28       Impact factor: 2.643

Review 9.  Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies.

Authors:  Atefeh Bakhtazad; Behzad Garmabi; Mohammad Taghi Joghataei
Journal:  J Neurovirol       Date:  2021-11-02       Impact factor: 3.739

Review 10.  Coronaviruses and the central nervous system.

Authors:  Susan Morgello
Journal:  J Neurovirol       Date:  2020-07-31       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.